Nextcure Inc. buy BiotechBee
Start price
10.12.23
/
60%
€1.24
Target price
31.07.25
€3.00
Performance (%)
-15.97%
End price
14.12.24
€1.04
Summary
This prediction ended on 14.12.24 with a price of €1.04. The prediction for Nextcure Inc. disappointed with a performance of -15.97%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Nextcure Inc. | - | - | - |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
According to BiotechBee what are the pros and cons of Nextcure Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Nextcure Inc. diskutieren
In the thread Trading Nextcure Inc.
Stopped prediction by BiotechBee for Nextcure Inc.
Nextcure Inc.
Start price
Target price
Perf. (%)
€1.51
04.02.23
04.02.23
€2.50
31.12.25
31.12.25
-3.93%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
